Expression of urokinase type plasminogen activator (u-PA) and U-PA inhibitor (PAI-1) in lung cancers: Clinical significance

被引：0
|
作者：
Brambilla, E [1 ]
Robert, C [1 ]
Bolon, I [1 ]
Decaussin, M [1 ]
机构：
[1] CHU Grenoble, Lung Canc Res Grp, Pathol Lab CJF 97 01, F-38043 Grenoble, France
来源：
LABORATORY INVESTIGATION | 1999年 / 79卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
1066
引用
收藏
页码：181A / 181A
页数：1
相关论文
共 50 条
  • [31] AN ENZYME-LINKED-IMMUNOSORBENT-ASSAY FOR UROKINASE-TYPE PLASMINOGEN-ACTIVATOR (U-PA) AND MUTANTS AND CHIMERAS CONTAINING THE SERINE PROTEASE DOMAIN OF U-PA
    DECLERCK, PJ
    VANKEER, L
    VERSTREKEN, M
    COLLEN, D
    THROMBOSIS AND HAEMOSTASIS, 1992, 67 (01) : 95 - 100
  • [32] PLASMINOGEN ACTIVATORS T-PA, U-PA AND ITS INHIBITOR (PAI) IN NORMAL MALES AND FEMALES
    KOH, SCL
    YUEN, R
    VIEGAS, OAC
    CHUA, SE
    NG, BL
    SEN, DK
    RATNAM, SS
    THROMBOSIS AND HAEMOSTASIS, 1991, 66 (05) : 581 - 585
  • [33] Effect of oxidative stress on the expression of t-PA, u-PA, u-PAR, and PAI-1 in endothelial cells
    Oszajca, Katarzyna
    Bieniasz, Magdalena
    Brown, George
    Swiatkowska, Maria
    Bartkowiak, Jacek
    Szemraj, Janusz
    BIOCHEMISTRY AND CELL BIOLOGY-BIOCHIMIE ET BIOLOGIE CELLULAIRE, 2008, 86 (06): : 477 - 486
  • [34] HIGH UROKINASE PLASMINOGEN-ACTIVATOR (U-PA) LEVELS IN ACUTE NONLYMPHOBLASTIC LEUKEMIA
    FRADE, LJG
    AVELLO, AG
    SUREDA, A
    LARANA, JG
    TORRADO, MC
    THROMBOSIS AND HAEMOSTASIS, 1991, 65 (06) : 1336 - 1336
  • [35] STAUROSPORINE STIMULATES EXPRESSION OF THE UROKINASE-TYPE (U-PA) PLASMINOGEN-ACTIVATOR IN LLC-PK1 CELLS
    DIERKSVENTLING, C
    KNESEL, J
    NAGAMINE, Y
    HEMMINGS, BA
    PEHLING, G
    FISCHER, F
    FABBRO, D
    INTERNATIONAL JOURNAL OF CANCER, 1989, 44 (05) : 865 - 870
  • [36] NO NET RELEASE OF T-PA, U-PA AND PAI-1 IN THE PULMONARY BLOOD COMPARTMENT
    KEBER, D
    KLOBOVES, V
    DOOIJEWAARD, G
    THROMBOSIS AND HAEMOSTASIS, 1993, 69 (06) : 830 - 830
  • [37] Plasminogen activators (u-PA, t-PA) and inhibitors (PAI-1, PAI-2) in blood of patients with Graves disease
    Zastawna
    Drewniak, W
    Rosc, D
    Michalski, A
    Kotschy, M
    THROMBOSIS AND HAEMOSTASIS, 1997, : PS606 - PS606
  • [38] Reduced dissemination of Lewis lung carcinoma in mice genetically deficient for urokinase-type (u-PA) plasminogen activator
    Stella, M
    DiPietro, N
    Diodato, E
    Dossi, C
    Nardulli, A
    Donati, MB
    Dewerchin, M
    Carmeliet, P
    Poggi, A
    THROMBOSIS AND HAEMOSTASIS, 1997, : OC803 - OC803
  • [39] BINDING OF UROKINASE-PLASMINOGEN ACTIVATOR (U-PA) TO MATRIGEL (TM) - EFFECTS ON PLASMINOGEN AND SINGLE-CHAIN-U-PA (SCU-PA) ACTIVATION
    VASUDEVAN, J
    GONIAS, SL
    THROMBOSIS AND HAEMOSTASIS, 1993, 69 (06) : 1084 - 1084
  • [40] A PLATELET INHIBITOR OF PLASMINOGEN ACTIVATORS - INTERACTIONS WITH T-PA AND U-PA
    BOOTH, NA
    BENNETT, B
    THROMBOSIS AND HAEMOSTASIS, 1985, 54 (01) : 270 - 270
12345